Skip to main content

McClellan Speaks On Healthcare Reform and the Future of Biomedical Innovation

This week at the CED Life Science Conference, Mark McClellan, M.D., director of the Duke-Margolis Center for Health Policy, discussed healthcare reform and biomedical innovation.

Pfizer Commits $4M to NCBiotech Gene Therapy Fellowship Program

Pfizer has committed to providing $4 million to enable the North Carolina Biotechnology Center to establish and administer a  multi-year academic fellowship program to help advance the state's gene therapy expertise.

LabCorp CEO David P. King to Keynote Triad BioNight 2017

The North Carolina Biotechnology Center has announced that LabCorp Chairman and CEO David P. King will be the keynote speaker for the March 30 Triad BioNight 2017 gala in Greensboro.

LabCorp's David P. King Keynotes Triad BioNight March 30

The North Carolina Biotechnology Center's Piedmont Triad Office and the Advisory Committee for Biotechnology in the Piedmont Triad will host Triad BioNight 2017 on Thursday, March 30.

Art Pappas Gets CED's 2017 Life Science Leadership Award

The Council for Entrepreneurial Development has picked North Carolina life science pacesetter Art Pappas, managing partner of venture capital firm Pappas Ventures, to receive its 2017 Life Science Leadership Award.

Pining for Truffles, Mycorrhiza Biotech Achieves First Harvest

When Nancy Rosborough read an article in the Washington Post about growing truffles, a gourmet delicacy that’s normally harvested from the wild, the novel idea took root as a Burlington biotech company.

NCBiotech Awards $1.4 Million in Latest Quarter

The North Carolina Biotechnology Center awarded 13 grants and loans totaling $1.4 million to universities and bioscience companies in the second quarter of its 2016-2017 fiscal year ending Dec. 31.

Locus Biosciences Lifts Lid on Crafty CRISPR to Bust Bad Bacteria

Raleigh bioscience startup Locus Biosciences, a spinout of North Carolina State University, is using a version of the hot gene-editing technology called CRISPR to cut a new path to the discovery and development of novel antibiotics.

Inside View: A Kind Gentleman and Nobel Laureate

It was a gray afternoon in March, 2008 at the North Carolina Biotechnology Center. A kindly looking gentleman stood in our Congressional Room, surrounded by a group of North Carolina’s brightest young scientists, winners of various science competitions across the state that year.

Two FDA Chiefs, Other Luminaries to Address CED Life Science Conference

Two former commissioners of the U.S. Food and Drug Administration, both with ties to Duke University, are among the speakers headlining the Council for Entrepreneurial Development’s 26th annual Life Science Conference in Raleigh Feb. 28 and March 1.

Pages

Subscribe to RSS - About Us